Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $9.31 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 50.19.
Market Cap
9.31T
Revenue
4.66T
Profits
185.53B
PE Ratio
50.19
Profit Margin
3.98%
Dividend Yield
0.38%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.10T | 3.90% | 3,011,882 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 630.94B | 0.99% | 8,985,115 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 438.19B | 0.78% | 4,209,941 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 371.19B | 0.41% | 3,182,189 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 323.00B | 1.82% | 6,007,619 | 66.57B |
| 6 | NVS | Novartis AG | 297.85B | 0.29% | 995,478 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 251.46B | 0.30% | 3,745,982 | 61.37B |
| 8 | AMGN | Amgen Inc. | 225.55B | 1.52% | 1,959,757 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 221.73B | 0.96% | 1,862,777 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 209.18B | 0.99% | 10,185,208 | 50.34B |
| 11 | ABT | Abbott Laboratories | 187.95B | 0.75% | 5,603,219 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 164.99B | -0.11% | 6,833,770 | 30.46B |
| 13 | PFE | Pfizer Inc. | 154.18B | 1.08% | 49,786,755 | 63.70B |
| 14 | DHR | Danaher Corporation | 147.18B | 2.25% | 3,678,062 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 138.97B | 3.85% | 3,221,561 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 132.79B | 5.61% | 2,682,320 | 12.59B |
| 17 | SYK | Stryker Corporation | 132.64B | 2.00% | 1,660,211 | 25.84B |
| 18 | BMY | Bristol-Myers Squibb Company | 132.45B | 0.19% | 9,753,263 | 49.19B |
| 19 | CVS | CVS Health Corporation | 122.36B | -0.03% | 7,025,234 | 412.65B |
| 20 | MDT | Medtronic plc | 114.45B | 2.58% | 6,572,304 | 36.36B |
| 21 | SNY | Sanofi | 104.53B | 0.05% | 3,356,087 | 55.89B |
| 22 | GSK | GSK plc | 104.44B | -1.51% | 3,136,165 | 44.05B |
| 23 | MCK | McKesson Corporation | 102.58B | 1.18% | 809,857 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 89.64B | 0.16% | 1,036,361 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.25B | 0.89% | 854,595 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.69B | 3.02% | 1,213,799 | 15.53B |
| 27 | CI | The Cigna Group | 73.56B | -1.45% | 1,458,184 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 73.13B | 2.33% | 18,994,453 | 21.00B |
| 29 | COR | Cencora, Inc. | 62.02B | 1.42% | 1,546,415 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.09B | 0.57% | 4,172,282 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 55.55B | 0.33% | 2,297,338 | 250.74B |
| 32 | ARGX | argenx SE | 55.41B | 0.12% | 361,409 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 53.05B | 2.57% | 4,443,995 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 48.93B | 1.57% | 1,765,860 | 22.48B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.93B | 1.55% | 579,107 | 4.55B |
| 36 | HUM | Humana Inc. | 46.31B | 0.18% | 1,150,468 | 145.68B |
| 37 | NTRA | Natera, Inc. | 45.89B | -1.16% | 2,154,605 | 2.71B |
| 38 | MDLN | Medline Inc. | 44.45B | -4.03% | 9,683,196 | 29.94B |
| 39 | RVMD | Revolution Medicines, Inc. | 44.36B | 0.89% | 2,101,103 | - |
| 40 | HLN | Haleon plc | 43.50B | -1.00% | 3,517,952 | 14.80B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 42.11B | 2.21% | 5,608,051 | 17.32B |
| 42 | A | Agilent Technologies, Inc. | 42.00B | 1.88% | 1,751,944 | 7.23B |
| 43 | ONC | BeOne Medicines AG | 40.82B | 3.08% | 833,361 | 6.13B |
| 44 | WAT | Waters Corporation | 40.43B | 1.21% | 826,606 | 4.64B |
| 45 | IQV | IQVIA Holdings Inc. | 39.83B | 1.38% | 1,161,447 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 38.12B | 1.83% | 1,786,556 | 3.32B |
| 47 | ALC | Alcon Inc. | 35.15B | 2.53% | 3,587,843 | 10.86B |
| 48 | RPRX | Royalty Pharma plc | 33.33B | 2.11% | 4,264,217 | 2.54B |
| 49 | DXCM | DexCom, Inc. | 33.08B | 3.42% | 7,832,725 | 4.97B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 32.95B | 1.63% | 3,254,879 | 21.27B |
| 51 | CNC | Centene Corporation | 32.89B | 1.22% | 3,720,007 | 180.30B |
| 52 | RMD | ResMed Inc. | 31.74B | 3.83% | 1,715,960 | 5.65B |
| 53 | ZTS | Zoetis Inc. | 30.92B | 2.99% | 9,610,019 | 9.53B |
| 54 | BIIB | Biogen Inc. | 30.60B | -0.39% | 706,425 | 10.03B |
| 55 | INSM | Insmed Incorporated | 29.43B | 2.78% | 3,630,056 | 1.14B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.03B | -1.01% | 1,404,831 | 4.80B |
| 57 | ILMN | Illumina, Inc. | 28.96B | 2.04% | 1,687,721 | 4.49B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.60B | -0.14% | 148,548 | 4.13B |
| 59 | PHG | Koninklijke Philips N.V. | 26.32B | 0.79% | 1,002,887 | 20.18B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.23B | -0.30% | 856,191 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 26.06B | 0.67% | 538,456 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 25.84B | -1.54% | 7,941,280 | 7.53M |
| 63 | WST | West Pharmaceutical Services, Inc. | 24.78B | -0.55% | 570,470 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.64B | 0.82% | 1,352,384 | 5.82B |
| 65 | MRNA | Moderna, Inc. | 23.88B | 1.08% | 6,224,526 | 2.23B |
| 66 | BNTX | BioNTech SE | 23.31B | -0.93% | 731,127 | 3.03B |
| 67 | STE | STERIS plc | 23.29B | 0.61% | 700,863 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.72B | -1.70% | 642,772 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 22.44B | -0.75% | 1,521,596 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 20.93B | -0.84% | 889,060 | 21.81B |
| 71 | VTRS | Viatris Inc. | 18.70B | -0.91% | 13,225,996 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.65B | 1.27% | 3,278,456 | 8.51B |
| 73 | GMAB | Genmab A/S | 18.37B | -1.22% | 2,799,566 | 4.13B |
| 74 | ASND | Ascendis Pharma A/S | 16.85B | 0.08% | 423,479 | 998.25M |
| 75 | MEDP | Medpace Holdings, Inc. | 16.81B | 1.99% | 233,639 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.76B | 0.92% | 935,227 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.65B | -0.02% | 896,552 | 4.60B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 16.55B | 0.22% | 2,942,576 | 713.07M |
| 79 | COO | The Cooper Companies, Inc. | 14.88B | 2.82% | 2,386,288 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.50B | 2.69% | 1,400,390 | 8.31B |
| 81 | BAX | Baxter International Inc. | 14.36B | 0.83% | 8,306,900 | 11.47B |
| 82 | BMRN | BioMarin Pharmaceutical Inc. | 13.33B | 7.95% | 5,036,931 | 3.41B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.22B | 3.56% | 1,025,376 | 4.00B |
| 84 | EXEL | Exelixis, Inc. | 13.12B | -2.05% | 3,349,674 | 2.44B |
| 85 | FMS | Fresenius Medical Care AG | 12.95B | 0.33% | 731,934 | 22.19B |
| 86 | RVTY | Revvity, Inc. | 12.94B | 1.19% | 1,253,851 | 2.91B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.86B | -1.57% | 2,361,863 | 14.37B |
| 88 | PEN | Penumbra, Inc. | 12.84B | 0.41% | 194,696 | 1.50B |
| 89 | ICLR | ICON Public Limited Company | 12.81B | 0.94% | 516,574 | 8.29B |
| 90 | SNN | Smith & Nephew plc | 12.57B | -0.10% | 1,093,045 | 6.30B |
| 91 | ALGN | Align Technology, Inc. | 12.51B | 1.37% | 643,615 | 4.14B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.48B | 0.78% | 854,408 | 669.50M |
| 93 | EHC | Encompass Health Corporation | 12.41B | 0.46% | 1,375,958 | 6.21B |
| 94 | CORT | Corcept Therapeutics Incorporated | 12.35B | 3.12% | 1,256,089 | 830.81M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.91B | 1.04% | 283,739 | 1.28B |
| 96 | SMMT | Summit Therapeutics Inc. | 11.86B | 6.52% | 3,491,648 | - |
| 97 | DVA | DaVita Inc. | 11.71B | -0.04% | 786,705 | 14.01B |
| 98 | HALO | Halozyme Therapeutics, Inc. | 11.65B | -0.48% | 4,934,990 | 1.66B |
| 99 | GMED | Globus Medical, Inc. | 11.57B | 4.61% | 3,024,975 | 3.14B |
| 100 | AXSM | Axsome Therapeutics, Inc. | 11.37B | 3.83% | 1,398,626 | 776.57M |
| 101 | TECH | Bio-Techne Corporation | 11.24B | -0.24% | 3,337,479 | 1.21B |
| 102 | ELAN | Elanco Animal Health Incorporated | 11.13B | 0.72% | 22,486,456 | 5.02B |
| 103 | ABVX | ABIVAX Société Anonyme | 11.06B | -2.62% | 763,961 | 5.67M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.77B | 0.95% | 2,270,665 | 67.67M |
| 105 | GKOS | Glaukos Corporation | 10.70B | 0.78% | 646,072 | 612.84M |
| 106 | ENSG | The Ensign Group, Inc. | 10.63B | 0.53% | 327,317 | 5.49B |
| 107 | MOH | Molina Healthcare, Inc. | 10.36B | 1.22% | 338,124 | 42.47B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 10.25B | 1.72% | 605,059 | 7.46M |
| 109 | UHS | Universal Health Services, Inc. | 10.18B | -0.46% | 730,361 | 18.11B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.11B | -0.14% | 761,300 | - |
| 111 | RDY | Dr. Reddy's Laboratories Limited | 10.11B | -0.57% | 1,967,271 | 3.50B |
| 112 | TEM | Tempus AI, Inc. | 9.93B | 5.78% | 6,781,500 | 1.43B |
| 113 | PODD | Insulet Corporation | 9.91B | 1.19% | 1,505,083 | 3.05B |
| 114 | HSIC | Henry Schein, Inc. | 9.82B | -0.06% | 1,401,362 | 13.60B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.81B | 1.57% | 151,952 | 440.48M |
| 116 | PTGX | Protagonist Therapeutics, Inc. | 9.71B | 2.83% | 545,974 | 281.99M |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 9.48B | 0.59% | 221,108 | 2.59B |
| 118 | IONS | Ionis Pharmaceuticals, Inc. | 9.46B | 0.67% | 2,399,897 | 874.09M |
| 119 | SYRE | Spyre Therapeutics, Inc. | 9.29B | 0.40% | 822,715 | - |
| 120 | AVTR | Avantor, Inc. | 9.29B | 1.03% | 6,427,950 | 6.56B |
| 121 | RGEN | Repligen Corporation | 9.21B | -0.45% | 770,771 | 785.10M |
| 122 | QGEN | Qiagen N.V. | 9.07B | 3.66% | 2,968,607 | 2.10B |
| 123 | KYMR | Kymera Therapeutics, Inc. | 9.03B | 0.99% | 404,887 | 105.00M |
| 124 | HQY | HealthEquity, Inc. | 8.93B | 2.06% | 623,931 | 1.34B |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.93B | 0.08% | 2,330,196 | 42.16M |
| 126 | PCVX | Vaxcyte, Inc. | 8.67B | 0.38% | 902,135 | - |
| 127 | BRKR | Bruker Corporation | 8.58B | 5.45% | 2,503,143 | 3.50B |
| 128 | OSCR | Oscar Health, Inc. | 8.53B | -0.82% | 6,563,760 | 15.32B |
| 129 | ATR | AptarGroup, Inc. | 8.50B | -1.28% | 446,750 | 3.93B |
| 130 | ALKS | Alkermes plc | 8.29B | 0.47% | 1,511,275 | 1.67B |
| 131 | IMVT | Immunovant, Inc. | 8.24B | -0.15% | 1,193,618 | - |
| 132 | LQDA | Liquidia Corporation | 8.10B | 0.90% | 1,650,113 | 288.07M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.95B | -0.13% | 738,554 | 239.92M |
| 134 | IBRX | ImmunityBio, Inc. | 7.94B | -1.96% | 6,001,571 | 165.79M |
| 135 | TWST | Twist Bioscience Corporation | 7.83B | 7.96% | 2,642,081 | 431.80M |
| 136 | PACS | PACS Group, Inc. | 7.67B | 0.02% | 611,888 | 5.55B |
| 137 | TXG | 10x Genomics, Inc. | 7.63B | 12.57% | 5,995,664 | 616.91M |
| 138 | HNGE | Hinge Health, Inc. | 7.39B | 2.51% | 2,195,558 | 720.06M |
| 139 | HIMS | Hims & Hers Health, Inc. | 7.35B | 0.57% | 17,688,775 | 2.58B |
| 140 | CHE | Chemed Corporation | 7.15B | -0.59% | 118,251 | 2.60B |
| 141 | COGT | Cogent Biosciences, Inc. | 7.10B | -2.03% | 1,616,940 | - |
| 142 | TGTX | TG Therapeutics, Inc. | 6.97B | -1.21% | 1,912,351 | 799.54M |
| 143 | GRFS | Grifols, S.A. | 6.94B | 1.39% | 273,506 | 8.48B |
| 144 | CGON | CG Oncology, Inc. | 6.79B | 1.94% | 811,296 | 6.23M |
| 145 | CAI | Caris Life Sciences, Inc. | 6.61B | 2.90% | 5,911,834 | 989.61M |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.03% | 1,402,332 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.58B | 2.58% | 120,991 | - |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 6.41B | -1.94% | 867,967 | 618.07M |
| 149 | ORKA | Oruka Therapeutics, Inc. | 6.34B | 6.40% | 872,775 | - |
| 150 | SRRK | Scholar Rock Holding Corporation | 6.32B | -1.95% | 827,075 | - |
| 151 | ERAS | Erasca, Inc. | 6.29B | -1.58% | 3,896,856 | - |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 6.25B | 2.64% | 861,275 | 1.90M |
| 153 | PTCT | PTC Therapeutics, Inc. | 6.23B | 1.80% | 826,179 | 1.01B |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 6.22B | 1.37% | 510,700 | 7.50M |
| 155 | RDNT | RadNet, Inc. | 6.08B | 6.76% | 1,780,519 | 2.27B |
| 156 | DFTX | Definium Therapeutics, Inc. | 6.07B | -2.15% | 2,311,081 | - |
| 157 | BLCO | Bausch + Lomb Corporation | 6.01B | 0.30% | 325,064 | 5.32B |
| 158 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.97B | 0.62% | 264,633 | 840.85M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 5.89B | 0.87% | 192,188 | 290.54M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.74B | -0.70% | 1,764,688 | 591.33M |
| 161 | AMRX | Amneal Pharmaceuticals, Inc. | 5.71B | -1.43% | 1,351,725 | 3.12B |
| 162 | TFX | Teleflex Incorporated | 5.64B | -1.47% | 586,085 | 2.25B |
| 163 | STVN | Stevanato Group S.p.A. | 5.62B | 1.53% | 501,629 | 1.40B |
| 164 | MMED | MiniMed Group, Inc. | 5.48B | -0.51% | 1,076,489 | 3.10B |
| 165 | SHC | Sotera Health Company | 5.41B | 0.58% | 3,287,668 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.36B | 0.80% | 1,371,455 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.17B | -0.02% | 1,186,853 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.06B | 0.62% | 2,726,434 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.95B | 0.95% | 3,022,998 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.84B | 2.44% | 2,018,084 | - |
| 171 | WAY | Waystar Holding Corp. | 4.74B | 1.94% | 3,393,367 | 1.21B |
| 172 | BLLN | BillionToOne, Inc. | 4.66B | 5.63% | 892,140 | 397.41M |
| 173 | MANE | Veradermics, Incorporated | 4.63B | -3.18% | 605,060 | - |
| 174 | DOCS | Doximity, Inc. | 4.57B | -6.46% | 9,955,219 | 655.57M |
| 175 | ICUI | ICU Medical, Inc. | 4.56B | -1.16% | 476,880 | 2.16B |
| 176 | PBLS | Parabilis Medicines, Inc. | 4.55B | 2.14% | 397,748 | - |
| 177 | LFST | LifeStance Health Group, Inc. | 4.55B | 9.78% | 10,564,467 | 1.58B |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.54B | -0.90% | 2,065,719 | 1.33B |
| 179 | NVST | Envista Holdings Corporation | 4.53B | 0.14% | 3,067,001 | 2.86B |
| 180 | CELC | Celcuity Inc. | 4.43B | -2.14% | 787,047 | - |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.37B | 0.86% | 2,672,105 | 10.35M |
| 182 | ELVN | Enliven Therapeutics, Inc. | 4.35B | -1.72% | 620,957 | - |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 4.35B | 0.12% | 982,228 | 2.29B |
| 184 | ITGR | Integer Holdings Corporation | 4.25B | -0.15% | 733,687 | 1.84B |
| 185 | LIVN | LivaNova PLC | 4.21B | 0.34% | 473,158 | 1.47B |
| 186 | IRTC | iRhythm Holdings, Inc. | 4.11B | -2.39% | 1,070,998 | 825.34M |
| 187 | ADPT | Adaptive Biotechnologies Corporation | 4.06B | 2.09% | 2,366,095 | 308.08M |
| 188 | VKTX | Viking Therapeutics, Inc. | 4.02B | 0.53% | 1,617,572 | - |
| 189 | TNGX | Tango Therapeutics, Inc. | 4.00B | 2.22% | 2,550,646 | 56.99M |
| 190 | LEGN | Legend Biotech Corporation | 4.00B | -0.43% | 2,239,418 | 1.14B |
| 191 | DNLI | Denali Therapeutics Inc. | 4.00B | 0.68% | 1,562,939 | 3.60M |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.99B | 2.34% | 82,624 | 803.79M |
| 193 | HAE | Haemonetics Corporation | 3.94B | -1.40% | 571,131 | 1.35B |
| 194 | GPCR | Structure Therapeutics Inc. | 3.82B | 1.25% | 358,693 | - |
| 195 | VCYT | Veracyte, Inc. | 3.72B | -2.01% | 761,912 | 561.90M |
| 196 | OPCH | Option Care Health, Inc. | 3.67B | 2.98% | 2,241,920 | 5.69B |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.66B | 0.35% | 912,850 | 117.00M |
| 198 | OGN | Organon & Co. | 3.58B | 0.15% | 1,464,153 | 6.13B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | -0.76% | 717,237 | 234.13M |
| 200 | ALMS | Alumis Inc. | 3.51B | -0.25% | 458,966 | 8.40M |
| 201 | NHC | National HealthCare Corporation | 3.46B | 2.55% | 123,699 | 1.56B |
| 202 | CLDX | Celldex Therapeutics, Inc. | 3.37B | 3.02% | 727,631 | 158.00K |
| 203 | NAMS | NewAmsterdam Pharma Company N.V. | 3.34B | 0.07% | 901,788 | 7.12M |
| 204 | GRAL | GRAIL, Inc. | 3.34B | 7.71% | 1,394,654 | 165.26M |
| 205 | BKD | Brookdale Senior Living Inc. | 3.27B | -3.73% | 8,430,281 | 2.98B |
| 206 | WRBY | Warby Parker Inc. | 3.26B | -0.19% | 1,751,992 | 911.61M |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | 2.49% | 2,094,919 | 463.98M |
| 208 | QURE | uniQure N.V. | 3.20B | -0.78% | 1,097,033 | 18.67M |
| 209 | MBX | MBX Biosciences, Inc. | 3.19B | -2.46% | 325,460 | - |
| 210 | TMDX | TransMedics Group, Inc. | 3.07B | 5.39% | 1,356,287 | 668.47M |
| 211 | IRON | Disc Medicine, Inc. | 3.01B | 1.08% | 308,429 | - |
| 212 | TARS | Tarsus Pharmaceuticals, Inc. | 2.97B | 4.58% | 947,744 | 606.33M |
| 213 | PLSE | Pulse Biosciences, Inc. | 2.96B | -2.12% | 486,699 | 1.19M |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 2.96B | 0.79% | 1,278,740 | 3.37B |
| 215 | IMNM | Immunome, Inc. | 2.91B | 2.64% | 1,232,630 | 4.02M |
| 216 | IOVA | Iovance Biotherapeutics, Inc. | 2.90B | 0.95% | 17,306,206 | 324.97M |
| 217 | ABCL | AbCellera Biologics Inc. | 2.86B | 34.78% | 46,039,057 | 66.17M |
| 218 | ALHC | Alignment Healthcare, Inc. | 2.86B | -4.11% | 5,919,482 | 4.58B |
| 219 | PRVA | Privia Health Group, Inc. | 2.86B | -0.36% | 1,318,115 | 2.36B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.74B | -1.20% | 762,175 | 830.44M |
| 221 | BEAM | Beam Therapeutics Inc. | 2.73B | -0.73% | 1,253,693 | 156.04M |
| 222 | KOD | Kodiak Sciences Inc. | 2.71B | -4.34% | 537,248 | - |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.69B | 1.37% | 898,977 | 36.77M |
| 224 | ATAI | AtaiBeckley Inc. | 2.68B | - | 3,450,719 | 3.49M |
| 225 | ZLAB | Zai Lab Limited | 2.65B | 1.07% | 1,698,221 | 449.61M |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.63B | 3.43% | 2,364,778 | 717.00M |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.63B | -5.38% | 454,686 | 1.46B |
| 228 | RGC | Regencell Bioscience Holdings Limited | 2.62B | -2.40% | 204,026 | - |
| 229 | VRDN | Viridian Therapeutics, Inc. | 2.61B | -2.25% | 2,268,723 | 71.13M |
| 230 | AXGN | Axogen, Inc. | 2.59B | 3.86% | 978,343 | 251.17M |
| 231 | BFLY | Butterfly Network, Inc. | 2.58B | 9.85% | 12,102,485 | 112.14M |
| 232 | TRVI | Trevi Therapeutics, Inc. | 2.54B | -3.84% | 1,024,066 | - |
| 233 | HTFL | HeartFlow, Inc. | 2.53B | 1.84% | 845,998 | 191.42M |
| 234 | NKTR | Nektar Therapeutics | 2.53B | -2.12% | 486,880 | 55.63M |
| 235 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.53B | -0.66% | 1,331,115 | -665.00K |
| 236 | UFPT | UFP Technologies, Inc. | 2.52B | 3.50% | 136,102 | 631.64M |
| 237 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.51B | 4.90% | 4,017,077 | 940.61M |
| 238 | PBH | Prestige Consumer Healthcare Inc. | 2.51B | -3.37% | 625,196 | 1.10B |
| 239 | PGEN | Precigen, Inc. | 2.51B | -3.18% | 4,753,489 | 85.72M |
| 240 | NEOG | Neogen Corporation | 2.49B | -0.61% | 1,622,409 | 870.40M |
| 241 | KLRA | Kailera Therapeutics, Inc. | 2.46B | 1.71% | 276,613 | - |
| 242 | CDNA | CareDx, Inc. | 2.44B | 0.81% | 1,228,966 | 458.09M |
| 243 | PHVS | Pharvaris N.V. | 2.43B | -0.20% | 982,001 | - |
| 244 | CLOV | Clover Health Investments, Corp. | 2.43B | -3.99% | 5,483,168 | 2.48B |
| 245 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 0.11% | 855,860 | - |
| 246 | BHC | Bausch Health Companies Inc. | 2.37B | 1.60% | 2,801,168 | 10.85B |
| 247 | COAG | Hemab Therapeutics Holdings, Inc. | 2.33B | 0.42% | 299,112 | - |
| 248 | XRAY | DENTSPLY SIRONA Inc. | 2.32B | -3.80% | 5,740,400 | 3.64B |
| 249 | WGS | GeneDx Holdings Corp. | 2.32B | 1.04% | 589,919 | 454.43M |
| 250 | NUVB | Nuvation Bio Inc. | 2.32B | - | 4,838,706 | 169.90M |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 2.27B | 1.54% | 564,502 | 959.90M |
| 252 | VERA | Vera Therapeutics, Inc. | 2.27B | -3.98% | 1,067,853 | - |
| 253 | URGN | UroGen Pharma Ltd. | 2.26B | -1.38% | 644,594 | 188.73M |
| 254 | RAPP | Rapport Therapeutics, Inc. | 2.25B | 3.28% | 265,839 | 20.00M |
| 255 | VCEL | Vericel Corporation | 2.25B | -2.53% | 415,810 | 306.30M |
| 256 | ESTA | Establishment Labs Holdings Inc. | 2.24B | -3.05% | 804,818 | 245.82M |
| 257 | HCM | HUTCHMED (China) Limited | 2.23B | 0.32% | 44,025 | 549.12M |
| 258 | MESO | Mesoblast Limited | 2.21B | 4.64% | 295,762 | 65.38M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 2.19B | -3.52% | 140,011 | - |
| 260 | BHVN | Biohaven Ltd. | 2.19B | -0.82% | 1,377,762 | - |
| 261 | ADMA | ADMA Biologics, Inc. | 2.18B | -1.52% | 1,898,733 | 512.28M |
| 262 | ADUS | Addus HomeCare Corporation | 2.18B | -0.28% | 199,231 | 1.48B |
| 263 | SLS | SELLAS Life Sciences Group, Inc. | 2.17B | -8.08% | 5,244,439 | - |
| 264 | PGNY | Progyny, Inc. | 2.14B | -0.89% | 1,272,770 | 1.31B |
| 265 | NEO | NeoGenomics, Inc. | 2.14B | 0.36% | 1,945,748 | 766.30M |
| 266 | ATRC | AtriCure, Inc. | 2.12B | 0.60% | 529,526 | 569.62M |
| 267 | STOK | Stoke Therapeutics, Inc. | 2.08B | -1.47% | 424,665 | 27.59M |
| 268 | MD | Pediatrix Medical Group, Inc. | 2.07B | -3.69% | 862,567 | 1.95B |
| 269 | SGRY | Surgery Partners, Inc. | 2.07B | 2.70% | 3,998,527 | 3.37B |
| 270 | AVAH | Aveanna Healthcare Holdings Inc. | 2.06B | -0.32% | 1,467,504 | 2.52B |
| 271 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | -2.52% | 1,050,211 | 311.51M |
| 272 | TSHA | Taysha Gene Therapies, Inc. | 2.04B | -2.90% | 2,240,388 | 7.47M |
| 273 | OCUL | Ocular Therapeutix, Inc. | 2.03B | 0.54% | 1,529,756 | 52.06M |
| 274 | GHRS | GH Research PLC | 2.03B | -2.44% | 213,703 | - |
| 275 | ZBIO | Zenas BioPharma, Inc. | 2.02B | -1.36% | 409,916 | 10.00M |
| 276 | NVCR | NovoCure Limited | 2.02B | 5.61% | 1,045,128 | 699.19M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.96B | 4.19% | 839,193 | 481.07M |
| 278 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | 0.99% | 1,071,535 | 98.34M |
| 279 | ALMR | Alamar Biosciences, Inc. | 1.94B | -1.65% | 270,193 | 87.16M |
| 280 | NBTX | Nanobiotix S.A. | 1.90B | -5.34% | 148,762 | 38.27M |
| 281 | GENB | Generate Biomedicines, Inc. | 1.89B | 2.58% | 523,322 | 26.48M |
| 282 | KARD | Kardigan, Inc. | 1.88B | 2.83% | 265,397 | - |
| 283 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.04% | 765,247 | - |
| 284 | LMAT | LeMaitre Vascular, Inc. | 1.86B | -0.32% | 468,315 | 262.43M |
| 285 | ASTH | Astrana Health, Inc. | 1.84B | 4.78% | 621,173 | 3.84B |
| 286 | BCAX | Bicara Therapeutics Inc. | 1.82B | -1.18% | 949,332 | - |
| 287 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -0.15% | 1,016,688 | 252.25M |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.82B | -1.27% | 216,197 | - |
| 289 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | 2.38% | 2,696,720 | 1.97B |
| 290 | FTRE | Fortrea Holdings Inc. | 1.81B | 3.04% | 1,035,814 | 2.68B |
| 291 | LKFT | Lakefront Biotherapeutics NV | 1.78B | -0.33% | 158,430 | 1.20B |
| 292 | CMPS | COMPASS Pathways plc | 1.78B | -2.66% | 1,817,585 | - |
| 293 | BRVE | Braveheart Bio, Inc. | 1.77B | -8.23% | 415,791 | - |
| 294 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 2.17% | 14,034,778 | 54.86M |
| 295 | PRGO | Perrigo Company plc | 1.75B | -1.56% | 2,006,608 | 4.14B |
| 296 | SEPN | Septerna, Inc. | 1.75B | 0.05% | 275,481 | 98.88M |
| 297 | IMCR | Immunocore Holdings plc | 1.75B | -0.06% | 301,785 | 430.78M |
| 298 | TRLV | Trulieve Cannabis Corp. | 1.75B | 3.77% | 623,442 | 1.14B |
| 299 | INSP | Inspire Medical Systems, Inc. | 1.73B | -0.73% | 585,409 | 898.74M |
| 300 | ZYME | Zymeworks Inc. | 1.71B | 2.63% | 819,975 | 37.13M |
| 301 | AAPG | Ascentage Pharma Group International | 1.70B | -0.68% | 3,471 | 82.08M |
| 302 | OMCL | Omnicell, Inc. | 1.70B | 1.36% | 529,257 | 1.25B |
| 303 | BLFS | BioLife Solutions, Inc. | 1.69B | -0.06% | 447,922 | 106.69M |
| 304 | NTLA | Intellia Therapeutics, Inc. | 1.68B | 0.67% | 3,032,375 | 59.51M |
| 305 | TRAX | First Tracks Biotherapeutics, Inc. | 1.67B | 5.71% | 708,832 | - |
| 306 | KMTS | Kestra Medical Technologies, Ltd. | 1.66B | 7.39% | 352,183 | 95.13M |
| 307 | ANAB | AnaptysBio, Inc. | 1.64B | -2.01% | 419,584 | 232.39M |
| 308 | AGL | agilon health, inc. | 1.63B | 1.33% | 397,282 | 5.92B |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.62B | -3.18% | 515,016 | 978.38M |
| 310 | XNCR | Xencor, Inc. | 1.60B | 3.70% | 1,263,698 | 104.97M |
| 311 | TNDM | Tandem Diabetes Care, Inc. | 1.59B | 1.92% | 2,320,684 | 1.04B |
| 312 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.58B | -2.57% | 2,242,949 | 208.78M |
| 313 | ARDT | Ardent Health, Inc. | 1.57B | -4.24% | 555,273 | 6.41B |
| 314 | TYRA | Tyra Biosciences, Inc. | 1.57B | -0.98% | 439,505 | - |
| 315 | PSNL | Personalis, Inc. | 1.55B | 2.40% | 4,209,330 | 69.67M |
| 316 | AVLN | Avalyn Pharma Inc. | 1.53B | 1.89% | 145,076 | - |
| 317 | OMDA | Omada Health, Inc. | 1.53B | 5.58% | 2,733,203 | 309.76M |
| 318 | ABSI | Absci Corporation | 1.53B | 0.90% | 2,969,511 | 1.84M |
| 319 | HROW | Harrow, Inc. | 1.52B | 0.64% | 803,907 | 275.59M |
| 320 | OBX | Obsidian Therapeutics, Inc. | 1.52B | 27.27% | 27,325 | - |
| 321 | MAZE | Maze Therapeutics, Inc. | 1.51B | -4.78% | 669,398 | 20.00M |
| 322 | VIR | Vir Biotechnology, Inc. | 1.50B | 0.79% | 1,487,216 | 303.23M |
| 323 | HCSG | Healthcare Services Group, Inc. | 1.50B | -1.98% | 720,356 | 1.86B |
| 324 | INVA | Innoviva, Inc. | 1.49B | 0.83% | 877,647 | 440.00M |
| 325 | CNMD | CONMED Corporation | 1.48B | 0.69% | 381,757 | 1.37B |
| 326 | INNV | InnovAge Holding Corp. | 1.48B | -2.50% | 214,599 | 949.17M |
| 327 | ATEC | Alphatec Holdings, Inc. | 1.47B | 1.93% | 1,973,875 | 815.05M |
| 328 | AZTA | Azenta, Inc. | 1.46B | 4.03% | 866,944 | 613.81M |
| 329 | XERS | Xeris Biopharma Holdings, Inc. | 1.46B | 0.76% | 1,616,128 | 335.41M |
| 330 | SVRA | Savara Inc. | 1.45B | -1.72% | 1,206,639 | - |
| 331 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 0.49% | 471,947 | - |
| 332 | MLTX | MoonLake Immunotherapeutics | 1.43B | -5.09% | 3,476,183 | - |
| 333 | AMN | AMN Healthcare Services, Inc. | 1.42B | 1.67% | 870,103 | 3.43B |
| 334 | ORIC | ORIC Pharmaceuticals, Inc. | 1.41B | 0.89% | 1,308,147 | - |
| 335 | SDGR | Schrödinger, Inc. | 1.40B | 3.36% | 1,199,701 | 259.04M |
| 336 | ENOV | Enovis Corporation | 1.40B | -8.91% | 1,756,160 | 2.30B |
| 337 | PAHC | Phibro Animal Health Corporation | 1.39B | -0.41% | 167,389 | 1.50B |
| 338 | PNTG | The Pennant Group, Inc. | 1.38B | 1.64% | 220,875 | 1.10B |
| 339 | JBIO | Jade Biosciences, Inc. | 1.38B | -1.05% | 634,987 | - |
| 340 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 5.02% | 337,144 | 1.30M |
| 341 | NUTX | Nutex Health Inc. | 1.35B | 21.87% | 379,879 | 846.72M |
| 342 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | -0.38% | 834,455 | 28.73M |
| 343 | ALVO | Alvotech | 1.35B | -1.05% | 1,022,803 | 562.04M |
| 344 | AKTS | Aktis Oncology, Inc. | 1.33B | -0.12% | 240,087 | 8.28M |
| 345 | IMTX | Immatics N.V. | 1.33B | 0.73% | 240,643 | 43.00M |
| 346 | IART | Integra LifeSciences Holdings Corporation | 1.33B | -1.04% | 686,199 | 1.65B |
| 347 | LBRX | LB Pharmaceuticals Inc | 1.31B | -4.48% | 425,932 | - |
| 348 | FRNM | Freenome, Inc. | 1.31B | 4.22% | 899,376 | 34.24M |
| 349 | NVAX | Novavax, Inc. | 1.30B | -0.75% | 3,225,294 | 413.80M |
| 350 | TDOC | Teladoc Health, Inc. | 1.29B | -0.70% | 4,566,695 | 2.49B |
| 351 | AORT | Artivion, Inc. | 1.28B | -2.99% | 728,090 | 471.47M |
| 352 | VOR | Vor Biopharma Inc. | 1.27B | -1.27% | 602,111 | - |
| 353 | MNKD | MannKind Corporation | 1.26B | -4.38% | 4,157,384 | 393.63M |
| 354 | STAA | STAAR Surgical Company | 1.25B | 3.76% | 804,964 | 290.38M |
| 355 | GDRX | GoodRx Holdings, Inc. | 1.25B | -0.54% | 2,475,607 | 785.23M |
| 356 | PRCT | PROCEPT BioRobotics Corporation | 1.24B | 6.37% | 2,015,875 | 337.34M |
| 357 | SPTX | Seaport Therapeutics, Inc. | 1.23B | -2.54% | 77,064 | - |
| 358 | CERT | Certara, Inc. | 1.23B | -1.59% | 3,057,088 | 421.75M |
| 359 | DRTS | Alpha Tau Medical Ltd. | 1.23B | 3.50% | 594,814 | - |
| 360 | USPH | U.S. Physical Therapy, Inc. | 1.22B | 2.11% | 200,225 | 804.27M |
| 361 | MGTX | MeiraGTx Holdings plc | 1.21B | -0.38% | 310,838 | 79.76M |
| 362 | ETON | Eton Pharmaceuticals, Inc. | 1.20B | -2.09% | 370,019 | 86.93M |
| 363 | WVE | Wave Life Sciences Ltd. | 1.20B | -0.49% | 2,565,557 | 65.37M |
| 364 | CGEM | Cullinan Therapeutics, Inc. | 1.18B | 3.10% | 663,852 | - |
| 365 | BVS | Bioventus Inc. | 1.17B | -1.20% | 917,011 | 581.85M |
| 366 | LTGO | Latigo Biotherapeutics, Inc. | 1.17B | 1.70% | 598,446 | - |
| 367 | AHG | Akso Health Group | 1.16B | - | 25,345 | 13.83M |
| 368 | CRVS | Corvus Pharmaceuticals, Inc. | 1.16B | -1.29% | 944,427 | - |
| 369 | IRMD | IRADIMED CORPORATION | 1.15B | -2.41% | 117,398 | 86.34M |
| 370 | REPL | Replimune Group, Inc. | 1.15B | 13.35% | 8,860,012 | - |
| 371 | IVA | Inventiva S.A. | 1.13B | -1.04% | 443,668 | 7.94M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 1.38% | 344,651 | 1.03B |
| 373 | EYPT | EyePoint, Inc. | 1.13B | -5.90% | 1,757,173 | 2.79M |
| 374 | APMD | Apnimed, Inc. | 1.11B | 3.48% | 352,642 | 120.15M |
| 375 | CRON | Cronos Group Inc. | 1.11B | -3.23% | 1,657,719 | 179.09M |
| 376 | ANRO | Alto Neuroscience, Inc. | 1.10B | -1.33% | 417,964 | - |
| 377 | SANA | Sana Biotechnology, Inc. | 1.08B | 2.56% | 2,755,128 | - |
| 378 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | -2.83% | 2,696,712 | 41.47M |
| 379 | ODTX | Odyssey Therapeutics, Inc. | 1.06B | 4.72% | 141,365 | 99.00K |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.06B | 7.91% | 977,860 | 59.00K |
| 381 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -0.91% | 724,111 | - |
| 382 | OPK | OPKO Health, Inc. | 1.04B | 1.46% | 2,562,562 | 587.90M |
| 383 | JANX | Janux Therapeutics, Inc. | 1.00B | 3.53% | 740,400 | 24.00M |
| 384 | ARDX | Ardelyx, Inc. | 996.75M | - | 10,814,226 | 450.89M |
| 385 | CSTL | Castle Biosciences, Inc. | 988.28M | 1.00% | 400,767 | 357.28M |
| 386 | OMER | Omeros Corporation | 985.75M | 2.79% | 1,390,698 | 9.89M |
| 387 | GMRS | GMR Solutions Inc. | 983.05M | 0.56% | 272,815 | 5.83B |
| 388 | PCRX | Pacira BioSciences, Inc. | 973.83M | -2.36% | 728,683 | 746.16M |
| 389 | GERN | Geron Corporation | 950.86M | - | 5,641,720 | 204.56M |
| 390 | QDEL | QuidelOrtho Corporation | 942.91M | 11.88% | 2,808,677 | 2.67B |
| 391 | SLDB | Solid Biosciences Inc. | 917.85M | 2.03% | 1,007,383 | - |
| 392 | ABUS | Arbutus Biopharma Corporation | 906.70M | -0.86% | 969,216 | 191.45M |
| 393 | GLAS | Glass House Brands Inc. | 897.72M | -1.18% | 330,465 | 177.68M |
| 394 | DSGN | Design Therapeutics, Inc. | 896.80M | 2.43% | 490,561 | - |
| 395 | COLL | Collegium Pharmaceutical, Inc. | 885.51M | -7.70% | 940,965 | 808.21M |
| 396 | ANNX | Annexon, Inc. | 883.11M | -0.37% | 1,960,169 | - |
| 397 | TBPH | Theravance Biopharma, Inc. | 877.47M | -0.12% | 427,636 | 104.31M |
| 398 | KURA | Kura Oncology, Inc. | 874.43M | 2.93% | 1,696,882 | 71.64M |
| 399 | AVR | Anteris Technologies Global Corp. | 873.20M | 0.56% | 1,069,693 | 1.85M |
| 400 | INMD | InMode Ltd. | 873.13M | -0.78% | 459,777 | 374.63M |
| 401 | TALK | Talkspace, Inc. | 868.92M | 0.38% | 847,271 | 245.73M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 868.47M | -0.17% | 1,593,822 | 8.22M |
| 403 | AMPH | Amphastar Pharmaceuticals, Inc. | 863.95M | -2.26% | 645,750 | 730.02M |
| 404 | HSTM | HealthStream, Inc. | 858.78M | 2.26% | 237,355 | 321.12M |
| 405 | ATTO | Attovia Therapeutics, Inc. | 853.70M | -1.64% | 376,599 | 1.35M |
| 406 | AURA | Aura Biosciences, Inc. | 849.31M | -3.63% | 499,249 | - |
| 407 | SIBN | SI-BONE, Inc. | 844.38M | 1.24% | 349,497 | 213.60M |
| 408 | SGP | SpyGlass Pharma, Inc. | 841.55M | -0.59% | 53,628 | - |
| 409 | DBVT | DBV Technologies S.A. | 837.46M | 5.86% | 474,061 | 5.04M |
| 410 | DRUG | Bright Minds Biosciences Inc. | 797.58M | 1.84% | 118,060 | - |
| 411 | OCS | Oculis Holding AG | 787.70M | 0.63% | 287,343 | 1.45M |
| 412 | MNPR | Monopar Therapeutics Inc. | 779.40M | -2.40% | 280,349 | - |
| 413 | RIGL | Rigel Pharmaceuticals, Inc. | 778.20M | 3.71% | 230,343 | 276.79M |
| 414 | VREX | Varex Imaging Corporation | 778.05M | 48.75% | 13,230,660 | 865.00M |
| 415 | CLYM | Climb Bio, Inc. | 777.69M | -3.29% | 779,554 | - |
| 416 | PHAR | Pharming Group N.V. | 777.52M | 3.65% | 62,601 | 366.48M |
| 417 | CADL | Candel Therapeutics, Inc. | 769.34M | -0.85% | 648,487 | - |
| 418 | PHR | Phreesia, Inc. | 768.94M | -0.56% | 543,527 | 495.59M |
| 419 | EVO | Evotec SE | 750.67M | 4.00% | 49,781 | 859.03M |
| 420 | SSII | SS Innovations International, Inc. | 750.49M | -0.53% | 18,542 | 48.47M |
| 421 | CTMX | CytomX Therapeutics, Inc. | 749.57M | -0.58% | 1,795,766 | 18.30M |
| 422 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 743.39M | -0.54% | 208,916 | - |
| 423 | CBIO | Crescent Biopharma, Inc. | 741.74M | 2.91% | 256,334 | 11.88M |
| 424 | AGMB | AgomAb Therapeutics NV | 738.72M | 3.45% | 87,437 | - |
| 425 | FTH | Faeth Therapeutics, Inc. | 738.26M | 17.14% | 261,256 | - |
| 426 | BBNX | Beta Bionics, Inc. | 737.83M | 3.14% | 1,316,058 | 119.01M |
| 427 | CBLL | CeriBell, Inc. | 732.29M | 2.60% | 424,074 | 101.96M |
| 428 | SLN | Silence Therapeutics plc | 728.82M | 29.12% | 16,208,741 | 615.00K |
| 429 | NGNE | Neurogene Inc. | 728.33M | 2.41% | 214,307 | 925.00K |
| 430 | ALLO | Allogene Therapeutics, Inc. | 724.82M | 4.48% | 5,360,498 | 22.00K |
| 431 | IMMX | Immix Biopharma, Inc. | 724.69M | 4.22% | 1,600,365 | - |
| 432 | GYRE | Gyre Therapeutics, Inc. | 712.55M | 0.75% | 53,246 | 109.82M |
| 433 | AHCO | AdaptHealth Corp. | 696.40M | -8.26% | 7,446,327 | 3.36B |
| 434 | RGNX | REGENXBIO Inc. | 687.86M | -2.80% | 988,833 | 174.48M |
| 435 | ACHV | Achieve Life Sciences, Inc. | 684.74M | 0.30% | 891,224 | - |
| 436 | ZVRA | Zevra Therapeutics, Inc. | 681.73M | -0.69% | 794,201 | 136.07M |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 680.72M | 0.23% | 2,146,414 | 239.66M |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 669.22M | -6.25% | 2,184,400 | 389.32M |
| 439 | TCMD | Tactile Systems Technology, Inc. | 657.29M | -1.22% | 636,236 | 350.31M |
| 440 | SOPH | SOPHiA GENETICS SA | 652.93M | -0.52% | 408,024 | 86.17M |
| 441 | ANGO | AngioDynamics, Inc. | 650.99M | 0.38% | 521,203 | 320.17M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 639.46M | 5.58% | 139,361 | - |
| 443 | STLN | Starling Oncology, Inc. | 627.80M | -3.90% | 2,681,239 | 587.24M |
| 444 | MDXG | MiMedx Group, Inc. | 622.40M | -1.61% | 1,156,128 | 355.17M |
| 445 | HELP | Cybin Inc. | 620.46M | -13.78% | 3,129,023 | - |
| 446 | NVCT | Nuvectis Pharma, Inc. | 614.98M | -0.40% | 137,150 | - |
| 447 | VSTM | Verastem, Inc. | 614.93M | 0.74% | 2,298,110 | 87.53M |
| 448 | BWAY | BrainsWay Ltd. | 613.20M | -1.16% | 55,215 | 56.22M |
| 449 | KIDS | OrthoPediatrics Corp. | 607.84M | 2.24% | 258,519 | 252.72M |
| 450 | CTKB | Cytek Biosciences, Inc. | 605.72M | 10.95% | 1,215,437 | 206.71M |
| 451 | TLRY | Tilray Brands, Inc. | 599.42M | -3.28% | 3,809,535 | 915.45M |
| 452 | ALT | Altimmune, Inc. | 593.15M | -0.97% | 5,260,453 | 36.00K |
| 453 | SGMT | Sagimet Biosciences Inc. | 590.96M | 5.63% | 1,799,217 | - |
| 454 | CRMD | CorMedix Inc. | 590.74M | 1.21% | 842,650 | 400.05M |
| 455 | ARVN | Arvinas, Inc. | 587.82M | 2.74% | 671,770 | 316.70M |
| 456 | SPRY | ARS Pharmaceuticals, Inc. | 586.88M | -4.06% | 1,330,193 | 98.99M |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 582.36M | 3.63% | 940,939 | 88.24M |
| 458 | DCTH | Delcath Systems, Inc. | 578.43M | 10.32% | 1,483,197 | 95.42M |
| 459 | CTEV | Claritev Corporation | 577.40M | 4.54% | 151,226 | 994.67M |
| 460 | PRME | Prime Medicine, Inc. | 560.40M | 2.27% | 3,595,813 | 4.07M |
| 461 | MPLT | MapLight Therapeutics, Inc. | 552.31M | 0.08% | 552,473 | - |
| 462 | AUTL | Autolus Therapeutics plc | 550.92M | -1.90% | 2,931,474 | 92.62M |
| 463 | ARTV | Artiva Biotherapeutics, Inc. | 548.55M | -0.44% | 178,961 | 251.00K |
| 464 | STTK | Shattuck Labs, Inc. | 547.50M | -1.79% | 901,856 | 1.00M |
| 465 | CTNM | Contineum Therapeutics, Inc. | 545.13M | -3.66% | 504,450 | - |
| 466 | AQST | Aquestive Therapeutics, Inc. | 538.25M | 8.88% | 7,295,515 | 50.27M |
| 467 | ZURA | Zura Bio Limited | 534.84M | -5.70% | 1,065,133 | - |
| 468 | ANL | Adlai Nortye Ltd. | 529.20M | -0.38% | 165,190 | 5.00M |
| 469 | EIKN | Eikon Therapeutics, Inc. | 526.77M | 4.74% | 504,716 | - |
| 470 | ENTX | Entera Bio Ltd. | 526.35M | 5.92% | 727,310 | 42.00K |
| 471 | BIOA | BioAge Labs, Inc. | 525.52M | -2.30% | 594,390 | 10.36M |
| 472 | SRTA | Strata Critical Medical, Inc. | 525.49M | 2.59% | 1,351,888 | 255.98M |
| 473 | FLGT | Fulgent Genetics, Inc. | 524.44M | -0.42% | 232,982 | 323.93M |
| 474 | DNA | Ginkgo Bioworks Holdings, Inc. | 515.15M | -4.02% | 1,324,659 | 132.42M |
| 475 | ASMB | Assembly Biosciences, Inc. | 514.77M | 0.22% | 105,718 | 71.10M |
| 476 | EVMN | Evommune, Inc. | 510.63M | -0.07% | 242,756 | 10.00M |
| 477 | PROK | ProKidney Corp. | 510.48M | 3.05% | 1,240,186 | 818.00K |
| 478 | VALN | Valneva SE | 510.43M | - | 49,120 | 180.25M |
| 479 | CERS | Cerus Corporation | 507.84M | 7.23% | 2,726,409 | 221.55M |
| 480 | NPCE | NeuroPace, Inc. | 507.31M | 0.34% | 234,544 | 99.53M |
| 481 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 482 | EOLS | Evolus, Inc. | 500.00M | -0.26% | 1,395,571 | 316.49M |
| 483 | OABI | OmniAb, Inc. | 492.87M | 10.06% | 1,841,351 | 38.46M |
| 484 | BLSM | BlossomHill Therapeutics, Inc. | 489.99M | -0.06% | 418,321 | - |
| 485 | OVID | Ovid Therapeutics Inc. | 489.00M | -0.38% | 1,252,320 | 7.12M |
| 486 | RZLT | Rezolute, Inc. | 488.90M | -0.21% | 756,464 | - |
| 487 | RLMD | Relmada Therapeutics, Inc. | 484.28M | -8.10% | 1,806,339 | - |
| 488 | IKT | Inhibikase Therapeutics, Inc. | 480.74M | -0.40% | 479,216 | 1.00 |
| 489 | KYTX | Kyverna Therapeutics, Inc. | 479.67M | -0.88% | 553,983 | - |
| 490 | PRLD | Prelude Therapeutics Incorporated | 479.03M | -1.43% | 217,169 | 16.72M |
| 491 | BNTC | Benitec Biopharma Inc. | 473.40M | 1.10% | 89,010 | - |
| 492 | SCTX | Scribe Therapeutics Inc. | 470.29M | -4.12% | 150,159 | 36.28M |
| 493 | PRTA | Prothena Corporation plc | 468.19M | 4.11% | 713,688 | 54.53M |
| 494 | QTTB | Q32 Bio Inc. | 466.49M | 0.45% | 439,597 | 53.74M |
| 495 | NRC | NRC Health | 462.30M | 2.75% | 130,553 | 140.00M |
| 496 | SLBT | SL Science Holding Limited | 457.40M | 5.99% | 62,764 | 3.27M |
| 497 | CABA | Cabaletta Bio, Inc. | 456.55M | 0.36% | 2,775,115 | - |
| 498 | PBYI | Puma Biotechnology, Inc. | 448.58M | -2.47% | 437,957 | 231.24M |
| 499 | NNNN | Anbio Biotechnology | 447.25M | -3.96% | 59,071 | 8.65M |
| 500 | CLPT | ClearPoint Neuro, Inc. | 444.45M | 2.53% | 423,689 | 42.28M |